Phase 2 data showed 24.2% mean weight loss at 48 weeks with 12 mg dose, the highest weight reduction reported for any single anti-obesity agent in Phase 2 trials, exceeding survodutide's 18.7%
Conducted by Eli Lilly, it included over 2,300 participants and showed up to 28.3% weight loss at an 80-week mark
If youre interested in medication options, make sure youre getting them through trusted healthcare providers and legitimate pharmacies
[1] [2] This medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptyingan effect that is most pronounced after initial doses and may attenuate over timeleading to reduced appetite and caloric intake
30-Day Steady Release System Each patch delivers ingredients through slow, controlled transdermal absorption , providing consistent support throughout the day
But lots of people end up stopping GLP-1s, often due to side effects or cost or thinking that they can maintain on their own without medication